OPTIMIZATION OF DIAGNOSIS AND PROGNOSIS OF THE COURSE OF BRONCHOPULMONARY PATHOLOGIES IN CHILDREN, TAKING INTO ACCOUNT METABOLIC DISORDERS

##plugins.themes.bootstrap3.article.main##

Abstrak:

Bronchopulmonary dysplasia, the most common received morbidity of preterm infants, is a extreme structure of continual lung disorder and is usually characterised through the presence of continual respiratory insufficiency and a supplemental oxygen requirement at 28 days of life with constant radiologic adjustments or persevering with need for oxygen therapy at 36 weeks’ postmenstrual age.

##plugins.themes.bootstrap3.article.details##

##submission.citations##:

Chengyin Y. Progressive Metabolic Abnormalities Associated with the Development of Neonatal Bronchopulmonary Dysplasia. Published online 2022.

What is bronchopulmonary dysplasia? https://www.hopkinsmedicine.org.

Asfia Banu Pasha. Bronchopulmonary dysplasia: Pathogenesis and treatment. Published online 2018.